Study | Test system | Exposure conditions: dose range and exposure time | Material | Dispersion procedure | Main conclusions |
---|---|---|---|---|---|
Urrutia-Ortega et al., 2016 [96] | Oral gavage, mice. Wild-type or model of CAC via AOM/DSS induction. | 5 mg/kg body weight/5 days/10 weeks | E171 | Sonication for 30 min in water | Reduced number of goblet cells in the distal colon, in both groups (WT and CAC), higher decrease in the CAC model. |
Talbot et al., 2018 [94] | HT29-MTX and in vivo rat acute and sub-chronic oral exposure | In vitro: 250 μg/mL; in vivo acute (7 days, daily gavage): 10 mg/kg bw/day; in vivo sub-chronic (60 days, drinking water): 10 and 0,1 mg/kg bw/day | E171 and P25 (anatase/rutile, 21 nm) | Probe sonication in 0,05% water/BSA 27 min | Penetration of TiO2 into the mucoid area of HT29-MTX cells (patchy structures of mucus). When E171 and P25 were administered in vivo, cecal short-chain fatty acid profiles and gut mucin O-glycosylation patterns remained unchanged |
Dorier et al., 2019 [95] | Caco-2/HT29-MTX co-culture | Acute (6-48 h; 50 μg/mL) or repeated twice a week for 3 weeks; 10 and 50 μg/mL) | E171, anatase 12 nm (A12), anatase/rutile, 21 nm (P25) | Indirect cup-type sonication (high energy) 30 min in water | No impact on cell differentiation. Inflammatory profile (chronic and acute), increased mucus secretion (chronic). Epithelial integrity unaltered, content of ABC family of xenobiotic efflux pumps modified (either increased or decreased depending on the particle: decreased with E171, increased with P25). |
Pinget et al., 2019 [133] | Mice, drinking water | 2, 10, 50 mg TiO2/kg b.w./day for 21 days | E171 | Suspension in drinking water | Decreased Muc2 gene expression in the colon at 10 and mg/kg b.w./day |
Medina-Reyes et al., 2020 [88] | Mice with either high fat diet (HFD) or regular diet (RD) | 5 mg/kg b.w. for 16 weeks | E171 | Suspension in drinking water | Hyperplasia and hypertrophy of goblet cells; increased Muc2, Muc5AC, Muc1 and Muc13 mRNA expression. |